BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

NxStage Medical, Inc. (NXTM) Launches New Home Hemodialysis Educational Resource


10/18/2013 9:14:36 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LAWRENCE, Mass., Oct. 17, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the launch of a new educational booklet that outlines the documented benefits and risks of home and more frequent home hemodialysis therapy. The booklet, entitled LIVE, is designed to be used by nephrologists, treatment modality educators, and dialysis providers to educate kidney patients on more frequent home hemodialysis. According to a survey conducted by the American Association of Kidney Patients and published in 2011, only about a third of dialysis patients reported that they were educated on home hemodialysis.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

"The benefits of more frequent hemodialysis at home are clear and compelling, so it is no surprise that our patients consistently tell us that the therapy gives them their lives back," said Joe Turk, President, NxStage Medical, Inc. "We urge everyone whether you are a kidney patient, you know a kidney patient, or you may come in contact with a kidney patient to read this booklet. With increased awareness of what could be comes the opportunity to change more lives for the better."

The LIVE booklet is organized into 3 sections Live Healthier, Live Better, Live Longer describing the clinical, quality of life and survival benefits reported in connection with home and more frequent hemodialysis, while also explaining the risks and responsibilities. In addition, there are quotes from current patients interspersed throughout the booklet, enhancing each topic with their real-world experience.

The LIVE booklet is available online at http://www.nxstage.com/live-brochure.

About the NxStage System One

The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation, and at a medically appropriate treatment frequency http://www.nxstage.com/.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2013. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE NxStage Medical, Inc.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES